<DOC>
	<DOCNO>NCT03023449</DOCNO>
	<brief_summary>This study non-randomized , Phase 2 clinical trial design measure cerebral blood flow ( CBF ) response inhale nitric oxide acute ischemic stroke patient healthy subject . The monitoring 35 minute session cerebral hemodynamics monitor diffuse correlation spectroscopy ( DCS ) transcranial doppler ultrasonography ( TCD ) blood pressure , heart rate , cardiac output , respiratory rate , end oxygen saturation , inhale nitric oxide ( NO ) /nitrogen dioxide ( NO2 ) concentration , continuously monitor .</brief_summary>
	<brief_title>Diffuse Optical Monitoring With Inhaled Nitric Oxide</brief_title>
	<detailed_description />
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Stroke Patients : 1 . Age great 18 2 . Acute ischemic stroke territory anterior , middle , posterior cerebral artery , either side brain 3 . Study initiate within 72 hour stroke symptom onset 3 . Ability willingness sign inform consent Healthy subject : 1 . Age great 18 2 . Ability willingness sign inform consent Stroke subject : 1 . History prior stroke transient ischemic attack 2 . Known cerebrovascular abnormality 3 . History congestive heart failure 4 . Presence pneumonia active pulmonary infection 5 . Current use NO donor medication ( sodium nitroprusside nitroglycerin ) 6 . Age le 18 year 7 . Skull defect would interfere CBF monitor 8 . Pregnancy 9 . Structural brain lesion 10 . Prior neurosurgical procedure 11 . History psychiatric disease 12 . Any medical condition clinical investigator feel would pose hazard subject he/she participate study Healthy subject : 1 . History neurological disease 2 . History stroke transient ischemic attack 3 . Known cerebrovascular abnormality 4 . History congestive heart failure 5 . History chronic pulmonary disease asthma COPD 6 . Presence pneumonia active pulmonary infection 7 . Current use NO donor medication ( sodium nitroprusside nitroglycerin ) 8 . Age le 18 year 9 . Skull defect would interfere CBF monitor 10 . Pregnancy ( urine blood test perform ) 11 . Structural brain lesion 12 . Prior neurosurgical procedure 13 . History psychiatric disease 14 . Any medical condition clinical investigator feel would pose hazard subject he/she participate study 15 . Cognitive impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>